Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07401290 · ClinicalTrials.gov registry record · NA
The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma
A NA study, sponsored by Vance Thompson Vision.
- Not yet
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT07401290: Clinical Trial NA study, sponsored by Vance Thompson Vision.
NCT07401290 is a NA study that has not yet begun recruiting, run by Vance Thompson Vision. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07401290, a NA study, has not yet begun recruiting, sponsored by Vance Thompson Vision.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Prospective, multi-center, single arm, interventional study evaluating DSLT in patients with pseudoexfoliative glaucoma.
Primary Outcome
Proportion of eyes achieving ≥20% reduction in washed-out IOP at month 6 compared to washed-out baseline IOP
Interventions
- DEVICE Direct selective laser trabeculoplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2026-03 |
| Est. Completion | 2028-03 |
| Phase | NA |
What is known before NCT07401290 opens enrollment
NCT07401290 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Direct selective laser trabeculoplasty is the first listed.
NCT07401290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07401290 about?
NCT07401290 is a clinical study titled "The Safety and Efficacy of Direct SLT in Pseudoexfoliation Glaucoma". Prospective, multi-center, single arm, interventional study evaluating DSLT in patients with pseudoexfoliative glaucoma.
What is the current status of trial NCT07401290?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-03. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07401290?
The interventions under investigation include: Direct selective laser trabeculoplasty (DEVICE).
Who is sponsoring clinical trial NCT07401290?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07401290's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia